Reuters ·  May 3 16:08
Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment